Stockreport

InflaRx Reports Full Year 2025 Results and Highlights Key Achievements and Expected Milestones

InflaRx N.V.  (IFRX) 
Last inflarx n.v. earnings: 8/14 04:05 pm Check Earnings Report
PDF Promising Phase 2a data announced for izicopan, underscoring its potential as a meaningfully differentiated, effective and safe oral inhibitor of C5aRSubstantial progres [Read more]